Drug Trial Radar · NCT03104517
Autologous Muscle Derived Cells Compared to Placebo for Urinary Sphincter Repair in Post-surgical Female Stress Incontinence
Last checked: Nov 19, 2026Latest source record: Oct 21, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
96
Planned (sponsor's estimate)
Start
Apr 23, 2019
Primary completion
Jun 11, 2026
Study completion Nov 2026
Sponsor
- Lead sponsor
- Cook MyoSiteIndustry
- Sponsor type
- Industry
- First posted
- Apr 7, 2017
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- Female only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study evaluates the efficacy and safety of Autologous Muscle Derived Cells for Urinary Sphincter Repair (AMDC-USR; generic name: iltamiocel) compared to a placebo in the reduction of stress incontinence episode frequency in adult female patients with post-surgical persistent or recurrent stress urinary incontinence (SUI). Half of the participants will receive AMDC-USR (injections with cells) and the other half will receive placebo.
Conditions
- Stress Urinary Incontinence
Interventions
AMDC-USR (iltamiocel)Biological
Autologous Muscle Derived Cells for Urinary Sphincter Repair (generic name: iltamiocel)
PlaceboOther
Placebo control is the vehicle solution used for the study product.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of leaks due to stress incontinence episodes, as recorded in a diaryTime frame: 12 months
Locations
21 sites in 2 countries. Site status is shown where the registry gives one.
Del Sol Research Management, LLC
Tucson, Arizona
San Diego Clinical Trials
La Mesa, California
UCLA Women's Health Clinical Research Unit/Department of OBGYN
Los Angeles, California
Stanford Hospital and Clinics
Stanford, California
American Association of Female Pelvic Medicines Research Institute
Westlake Village, California
MedStar Georgetown Hospital Department of Urology
Washington D.C., District of Columbia
University of Kansas Health System
Kansas City, Kansas
Bennett Institute of Urogynecology and Incontinence
Grand Rapids, Michigan
University of New Mexico Women's Care Clinic
Albuquerque, New Mexico
AccuMed Research Associates
Garden City, New York
Northwell Health/The Arthur Smith Institute for Urology
Lake Success, New York
Columbia University Irving Medical Center
New York, New York
Atrium Health
Charlotte, North Carolina
Cleveland Clinic/Glickman Institute-Q10
Cleveland, Ohio
Magee Women's Hospital of UPMC
Pittsburgh, Pennsylvania
Sanford Female Pelvic Medicine and Reconstructive Surgery Clinic
Sioux Falls, South Dakota
Vanderbilt University Medical Center, Dept. of Urologic Surgery
Nashville, Tennessee
Houston Methodist Hospital
Houston, Texas
Cedar Health Research
Irving, Texas
Virginia Mason Medical Center
Seattle, Washington
Derriford Hospital
Plymouth, Devon, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.